Point72 Asset Management’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-101,372
| Closed | -$906K | – | 1845 |
|
|
2023
Q3 | $906K | Buy |
101,372
+99,848
| +6,552% | +$892K | ﹤0.01% | 928 |
|
|
2023
Q2 | $13.1K | Buy |
+1,524
| New | +$13.1K | ﹤0.01% | 1334 |
|
|
2022
Q2 | – | Sell |
-29,587
| Closed | -$2.39M | – | 1243 |
|
|
2022
Q1 | $2.39M | Sell |
29,587
-1,233
| -4% | -$99.7K | 0.01% | 770 |
|
|
2021
Q4 | $6.25M | Sell |
30,820
-4,320
| -12% | -$875K | 0.02% | 590 |
|
|
2021
Q3 | $9.47M | Buy |
+35,140
| New | +$9.47M | 0.04% | 473 |
|
|
2020
Q2 | – | Sell |
-1,045
| Closed | -$280K | – | 914 |
|
|
2020
Q1 | $280K | Buy |
+1,045
| New | +$280K | ﹤0.01% | 668 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 1099 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 1273 |
|
|
2018
Q2 | – | Sell |
-1,473
| Closed | -$2.35M | – | 943 |
|
|
2018
Q1 | $2.35M | Buy |
+1,473
| New | +$2.35M | 0.01% | 583 |
|
|
2016
Q2 | – | Sell |
-613
| Closed | -$127K | – | 754 |
|
|
2016
Q1 | $127K | Sell |
613
-554
| -47% | -$115K | ﹤0.01% | 622 |
|
|
2015
Q4 | $295K | Sell |
1,167
-8,000
| -87% | -$2.02M | ﹤0.01% | 596 |
|
|
2015
Q3 | $1.51M | Buy |
+9,167
| New | +$1.51M | 0.01% | 540 |
|